Motivation: To promote a systems biology approach to understanding the biological effects of environmental stressors, the Chemical Effects in Biological Systems (CEBS) knowledgebase is being developed to house data from multiple complex data streams in a systems friendly manner that will accommodate extensive querying from users. Unified data representation via a single object model will greatly aid in integrating data storage and management, and facilitate reuse of software to analyze and display data resulting from diverse differential expression or differential profile technologies. Data streams include, but are not limited to, gene expression analysis (transcriptomics), protein expression and proteinprotein interaction analysis (proteomics), and changes in low molecular weight metabolite levels (metabolomics).
INTRODUCTION
Current research trends emphasize the need to integrate data from studies monitoring changes in expression of genes, proteins and metabolites as a consequence of perturbing biological systems (Ideker et al. 2001 , Waters et al. 2003 . Comparisons of gene, protein, and metabolite data will be invaluable in promoting a global understanding of how biological systems function and respond to environmental stressors (Amin et al. 2002 , Witzmann et al. 2003 , Lindon et al. 2003 . The Chemical Effects in Biological Systems (CEBS) toxicogenomics knowledge base is designed to integrate data resulting from these three disciplines in addition to conventional toxicology data. (Waters et al. 2003) . A standard representation of data types within each discipline is an important pre-requisite for efficient and accurate storage, access, analysis, comparison, and data exchange. Furthermore, valid conclusions are possible only if the data is sufficiently well annotated with contextual information regarding its origin. These observations have led to the development of a draft MIAME/Tox guideline (http://www.mged.org/MIAME1.1-DenverDraft.DOC) and the formation of an MGED Toxicogenomics Working Group (mged-tox@lists.sourceforge.net) that addresses minimum information about a microarray experiment in the realm of toxicogenomics. Encapsulation of toxicogenomics data access and representation within a common object model will greatly facilitate software reuse and rapid application development. The SysBio-OM was developed around these two major concerns. Below, we illustrate the experimental scenarios in transcriptomics, proteomics, and metabolomics disciplines that helped formalize the requirements of the integrated model design. The model can also be extended to accommodate additional data streams from these or additional disciplines.
Transcriptomics
High throughput platforms such as microarrays (Chu et al. 1998) and Serial Analysis of Gene Expression (SAGE; Velculescu et al. 1995) have evolved to monitor gene expression patterns in biological samples. The research objective is often focused on quantitative comparisons of gene expression between control states and states induced by specific chemicals, diseases, environments, or therapeutic treatments. The general workflow of a typical DNA microarray experiment consists of hybridizing fluorescently labeled mRNA from control and experimental samples to DNA microarray chips on which thousands of gene specific reporter(s) sequences are arrayed. Images of the array are then acquired and analyzed to obtain the ratio of control and experimental signal intensities, which enable the inference of relative fold changes in gene expression exerted by the experimental treatment or disease state. The basic concept of SAGE rests on two principles: first, a small sequence of nucleotides from the transcript, called a 'tag', can effectively identify the original transcript from whence it came, and second, these tags can be linked enabling rapid sequence analysis of multiple transcripts. The number of times that a specific transcript is identified in a given sample is used as an indicator of the level of gene expression corresponding to the transcript.
Proteomics
Proteomics research involves measurement of changing protein expression profiles as affected by chemical toxicity, disease state, environmental insult, or therapeutic treatment. The plethora of proteomics platforms reflects the choice of measuring specific attributes of proteins including protein identity (amino acid sequence), mass, charge, posttranslational modifications, protein-protein interactions, subcellular location and biological activity. Currently, most proteomics laboratories employ combinations of proteomics platforms since no single technique can measure all protein characteristics in a comprehensive manner (Figeys et al. 2003) . Consequently, several scenarios for proteomics experiments can be envisioned, as illustrated below, reflecting the complex workflow in these experiments.
Depending on the cellular compartment of interest, procedures for organelle separation (Rappsilber et al. 2002 , Galeva et al. 2002 may be used prior to proteomic analysis. Separation of protein constituents by column chromatography (Gorg et al. 2002) or immunoprecipitation (Gronborg et al. 2002) can be used to exploit differences in physical (size, hydrophobicity, charge) or other chemical (covalent or noncovalent interactions with other proteins, ions, compounds, resins) attributes. Proteins may be tagged with compounds in certain quantitative protein expression measurement such as Difference Gel Electrophoresis (DIGE; Unlu et al. 1997 ) using fluorescent tags or Isotope-Coded Affinity Tagging (ICAT; Gygi et al. 1999 ) involving isotopically labeled cross linkers. A prime strategy for proteomics analysis has been to use global protein stratification systems prior to protein identification by mass spectrometry (MS). For example, separation of proteins by charge (first dimension) and mass (second dimension) can resolve thousands of proteins to near homogeneity, a necessary prerequisite to enzymatic digestion and MS analysis. Such pre-purification steps enable the generation of unique sets of peptide fingerprint masses or amino acid sequence tags. Where liquid chromatography (LC) is used as a means of separation prior to MS, a new and promising platform involving multidimensional LC can be used to fractionate and reduce the complexity of the protein mixture prior to peptide sequencing by MS. The resulting tryptic peptide list, generated by MS, is submitted to database search engines such as SEQUEST (Yates et al. 1995) , MASCOT (Perkins et al. 1999) , ProteinProspector (Clauser et al. 1999) or ProFound (Zhang et al. 2000) , which report a ranked list of possible peptides and protein identifications based on database matches.
Forward phase protein microarrays can be used to capture a protein from a sample solution using an immobilized bait. Reverse phased protein microarrays involve the use of a labeled analyte-specific ligand to capture the analyte in an immobilized test sample (Liotta et al. 2003) . Yeast 2 hybrid screening (Fields et al. 1989) represents another type of affinity based proteomics experiment. Affinity based proteomics experiments may be used in conjunction with other techniques such as MS to identify the interacting proteins (Rigaut et al. 1999 , Gavin et al. 2002 .
Metabolomics
Differences in metabolite profiles based on chemical induced toxicity, disease state, environmental insult, or therapeutic treatment can also be used to understand mode-of-action. The two "omics" terms, metabolomics and metabonomics are most commonly applied in this area of research and focus on examining low molecular weight (< 1,000 amu) biochemicals such as metabolites and small peptides. Most researchers believe the two terms are interchangeable, while others distinguish metabolomics as describing cell-based metabolism research in phylogenetically-lower systems, and metabonomics as describing global metabolite profiling research at the organ and biofluid level in mammalian systems. Nuclear magnetic resonance spectroscopy (NMR) and MS are the most common detection techniques used in metabo(n,l)omic studies (Sumner and Liu, 2002 , Plumb et al. 2002 , Nicholson et al. 1999 , although any spectroscopic method that detects low molecular weight compounds can suffice.
MS and NMR methods are preferred due to the combination of detection capability, sensitivity, and broad range of metabolite analysis achieved within one spectral acquisition. NMR analysis can be accomplished directly on biofluids (such as serum and urine) following addition of a compound (such as deuterium oxide) to provide a reference lock signal (Nicholson et al. 1999) . High resolution magic angle spinning NMR methods can be used to obtain spectra on tissues without a requirement for extraction of the metabolites (Tate et al. 2000) .
Although more sensitive than NMR, MS analysis requires extraction of metabolites from cells, organs, and most biofluids. In addition to extraction of metabolites, chromatographic methods are coupled to MSMS methods to provide separation of compounds within the same compound classifications. Gas chromatography (GC) and LC are two common separation techniques that can be directly coupled to MS detection (GC-MS and LC-MS). LC is also becoming a more common hyphenated NMR method, and the extraction procedures used prior to MS analysis can also be used prior to NMR analysis to provide increased resolution and detection of less abundant compounds.
Regardless of the sample preparation, chromatography, or detection methods, unless metabolites are assigned, the profiles generated can be used only in differential analysis. The resulting spectra can be statistically analyzed with data reduction algorithms, such as principal component analysis, or comparison with the spectra of known metabolites to align, visualize, and differentiate components within the experimental samples. A standards library for spectral matching can be developed for commercially available or custom synthesized compounds. This approach relies on having the correct compound for matching within the library. Peaks detected in NMR spectra carry information regarding the structure of the metabolites, and peaks detected by MS have associated molecular weights. NMR and MS are routinely used jointly in assignment for unknown metabolites. In addition, specific MS methods can be established for fragmentation of the parent molecule, and through investigation of fragmentation patterns, metabolites can be identified.
General Workflow of Systems Biology Experiments
The experiments described above for transcriptomics, proteomics or metabolomics experiments suggest a general workflow for processing of biological samples, specific protocols for analysis and experimental metadata. Signal generation and image analysis produce data files (e.g., spot list file) with raw numeric data (e.g., spot intensities). The raw data can be transformed to generate derived data by statistical and data reduction processes to enable appropriate comparisons and visualization of large data sets.
RESULTS
Although transcriptomics, proteomics, and metabolomics experiments share the same general workflow, we are not aware of any single, common platform to represent, store and access proteomics, metabolomics, and gene expression data in a standard form. Below we present our efforts to combine the strengths of two open source object models, MAGE-OM developed by the Microarray Gene Expression Database (MGED) Society (Spellman et al. 2002 ; vetted through the Object Management Group (OMG)) and the Proteomics Experiment Data Repository, PEDRo, (Taylor et al. 2003 ; vetted through the Human Proteome Organization (HUPO) (http://psidev.sourceforge.net/meetings/2003-01/2003-01-report.html)) in a manner that enables us to render the data such that it is readily accessible via a uniform, cross-technology object model. We are not aware of any open source model for representing metabolomics data. Both the MAGE and PEDRo models offer several reusable features, as discussed below.
The MAGE-OM has been designed to represent microarray gene expression data, while the PEDRo model represents data resulting from protein expression experiments involving gel electrophoresis, MS, and liquid chromatography combined with tandem MS (LC/MS/MS). Besides enabling users to describe experimental protocols and the resulting data, both models also enable users to represent contextual information such as the characteristics of the organism (i.e., species, age, sex, developmental stage, disease state etc) from which the sample was isolated, cell or tissue type, the environmental perturbation that the cell or organism was subjected to, and the sample isolation/preparation protocols.
The MAGE-OM and PEDRo models promote the standardization of annotation through the use of controlled vocabulary, which facilitates efficient storage and exchange of annotated data while providing access to multiple annotation resources. The MGED Society has developed a core ontology and is integrating domain specific ontologies, which can be used within the MAGE framework. Currently available guidelines for defining microarray experiments are the Minimum Information about Microarray Experiment (MIAME) and the draft MIAME-Tox mentioned above. The PEDRo model is designed to capture annotations about column chromatography, gel electrophoresis and MS experiments adequately so as to enable valid data comparison across two or more proteomics studies.
As mentioned earlier, an important requirement for efficient exchange of data is to use standardized data exchange formats. XML (Extensible Markup Language; http://www.w3.org/TR/xml11/) is a well-defined open source data standard that enables data to be automatically parsed for web display, and has been utilized to exchange data between diverse technology platforms. XML representations of the MAGE-OM, Microarray Gene Expression Markup Language (MAGE-ML) (Brazma et al. 2001) and PEDRo, Protein Experiment Markup Language (PEML) (Taylor et al. 2003) have been defined, and are expected to be the formats for microarray and proteomic data exchange, respectively, between repositories. These internationally accepted formats will enable automation of the submission of data to sources that support such formats. Indeed, some commercial microarray platform vendors, such as Affymetrix are building tools to support MAGE-ML document generation (http://www.affymetrix.com/support/developer/exporter/GDACExporter/Pages/GDACExporter_home.affx) . Several data repositories including CEBS and ArrayExpress (Brazma et al. 2003) will accept and produce MAGE-ML representations of submitted microarray experiments
The MAGE-OM and PEDRo models differ in the flexibility of their framework. PEDRo is protein expression-oriented and is not designed to interact with data acquired from nonproteomics studies. MAGE-OM has been developed to represent microarray data, and can be used for both DNA and forward phase protein arrays (Liotta et al. 2003) . Moreover, MAGE-OM also offers an extensible framework to capture the workflow for other types of experiments including proteomics and metabolomics experiments. This flexibility stems from the fact that several of the MAGE-OM objects are designed for compatibility with experiments other than microarray gene expression.
The above considerations led us to design and implement the CEBS Systems Biology object model (SysBio-OM) in which elements representing information from PEDRo, and from protein-protein interaction and metabolomics experiments are integrated into MAGE-OM architecture. Such a model can enable the proper annotation of all of these experiments while being able to generate output files in the MAGE-ML and PEML formats. The ability to incorporate standard vocabulary and ontologies will greatly improve the quality and usability of transcriptomics, proteomics, and metabolomics data. Use of common vocabulary also enables users to take advantage of alternative annotation sources. Finally, the extensible nature of a MAGE-PEDRo hybrid object model also enables the representation of future experiments in these disciplines.
Description of the SysBio-OM
The SysBio-OM is designed to foster the efficient capture, storage, retrieval, and exchange of wellannotated microarray gene expression, proteomics, and metabolomics experimental data sets. The SysBio-OM described here is similar to the MAGE-OM in that it is a data centric model. The existing packages and classes within MAGE-OM have been reused to the extent possible to represent elements of proteomics and metabolomics experiments. For additional objects that have been added, every effort has been made to be consistent with the MAGE-OM and PEDRo nomenclature. Importantly, several experimental techniques such as chromatographic separation and MS, and data features, such as peaks and fractions are common to both proteomics and metabolomics. This has enabled the use of objects to model both proteomics and metabolomics experiments leading to a more concise model. Results from proteomics and metabolomics experiments are modeled by elements in the CommonBioassayData package. Summary data is modeled by classes defined in the SummaryData package.
A Universal Modeling language (UML) (Rumbaugh et al., http://www.rational.com) depiction of the entire object model is available at http://cebs.niehs.nih.gov/. Elements and events are represented by classes (shown as boxes), which have attributes and may have varied relationships such as aggregation, inheritance, directed or bidirectional association (shown as different types of lines and explained in the legend of Figure 1 ) to one another. The packages in the SysBio-OM are used to organize classes that share a common purpose and are shown in Table 1 . One distinguishing feature of proteomics experiments is that samples output from one assay (for example gel electrophoresis) are often the input for the next assay (for example MS). Each consecutive assay results in data that needs to be tracked sequentially. For example, a gel spot should be tracked back to the chromatographic fraction that was the input of the gel electrophoresis experiment. Furthermore, the physical BioMaterial elements such as gel spots must be linked to the quantitation data associated with the spot. Similarly, in metabolomics experiments, samples can be first subjected to chromatographic separation before analysis by NMR or MS. The hyphenated techniques allow for real-time flow into NMR or MS detection systems, and the output contains information from the detection system (chemical shift, NMR; molecular weight, MS), and also from the chromatographic system (retention time of analyte). Consequently, subclasses of BioMaterials such as SpotMaterial, BandMaterial, ColumnFractionMaterial, PeakMaterial were modeled and linked to the corresponding data values (Spot, Band, ColumnFraction, Peak). Some of the representative classes of this package are shown in Figure1.
Figure 1 here BioEvent
BioEvent, an abstract class in the BioEvent package models events that take sources of some type (for example input sample or data) to produce a target of another type (for example, output sample or data), the types determining the subclasses of BioEvent. BioAssayCreation, a class derived from BioEvent represents a microarray-specific process that hybridizes a set of materials to an Array to produce a PhysicalBioAssay (see below). BioEvent via its association to ProtocolApplication (see below under Protocol) enables the determination of the protocols applied to the specific BioEvent. 
BioAssay
Classes in the BioAssay package contain information and annotation pertaining to BioAssayCreation and CommonBioAssayCreation events, acquisition of data (eg., ImageAcquisition, NMRDataAcquistion), and extraction of measurements (eg., intensity) for individual elements (eg., Spot or Peak) from raw data (eg., GelFeatureExtraction of Images). The derived classes of the abstract class BioAssay are PhysicalBioAssay, MeasuredBioAssay, and DerivedBioAssay. PhysicalBioAssay represents the process that leads to production of physical data such as an Image, MassSpecOutputfile, NMROutputFile, ColumnFractionOutputFile, or the more generic DataOuputFile generated from the assays such as OneDGelElectrophoresis, TwoDGelElectrophoresis, MassSpectrometry, NMR, ColumnFractionation, AffinityExperiment, and TwoHybridScreeen. The classes that represent these physical data enable us to model attributes such as the file format, the URI where the files are located, and the channels that were used to generate an image (Cy2, Cy3, and Cy5 for Differential Gel Electrophoresis). PhysicalBioassay has an association with BioAssayTreatment which enables identification of the treatment used to generate the corresponding dataset. PhysicalBioassay also has an association to CommonBioAssayCreation. MeasuredBioAssay is associated with the dataset produced by Bioevents such as GelFeatureExtraction, PeakListGeneration. DerivedBioAssay groups BioAssays that have been analyzed in combination to further refine the quantitations. Some of the representative classes of this package are shown in Figure 2 .
Figure2 here Protocol
ProtocolApplication enables the specification of how an event was performed. This class and its associated classes (Protocols-Hardware and Software) can be used to specify the parameter values for the Bioassay. Protocol subclasses have been added to allow the description of the minimum information to be supplied for specific types of proteomics and metabolomics experiments. To retain the original MAGE Protocol class, methods were added to the subclasses to display the expected behavior, as opposed to adding new attributes that would have altered the behavior of Protocol. These methods access the underlying Parameter collection to store the attributes that are set. Subclasses of Protocol specified in this model represent protocols for column fractionation, gel electrophoresis, MS, including protocols for ionization, analysis and detection steps, NMR, and database searching for protein identification. Some of the representative classes of this package are shown in Figure 3 .
Figure 3 here CommonBioAssayData
Classes in the CommonBioAssayData package model the proteomics and metabolomics data and the information and annotation on the derivation of that data. Data points are represented as 3-dimensional matrices, the CommonBioAssayDatum, with the bioassay, the DataElement whose properties are being measured (Spot, Peak, Band, ProteomicReporter) and quantitation type (spot coordinates, spot intensity, mass/charge (m/z value)) along the three dimensions. An example is as follows: GelFeatureExtraction of an Image produces MeasuredCommonBioAssayData (derived from the class CommonBioAssayData) with a single BioAssay on the BioAssay dimension, the Spot in the Image of the Gel along the DataElement dimension, and the quantitations such as Intensity, Spot coordinates, Area, and Volume, etc., associated with the application of a GelFeatureExtraction protocol on the quantitation Dimension. Similarly, the readout of an NMROutputFile leads to generation of MeasuredCommonBioAssayData with an NMR experiment on the BioAssay dimension, Peak in the spectra along the DataElement dimension and the quantitations such as Intensity, ChemicalShift ( ) resulting from a read out of the spectra. Data values generated from the DerivedBioAssay will be dimensions of the tuples of DerivedCommonBioAssayData. Processes such as Normalization, ListProcessing, Principal ComponentAnalysis (can be used to convert raw values for spot or peak data into transformed spot or peak data), PeakSpecificChromatogramIntegration (integrate the area within a specific isotope peak), ProteinIdentificationUsingSequenceTags and, MetaboliteIdentificationOfPeaks are types of DataTransformation. The class, MatchedProtOrPep, a specialized class of DataElement enables capture of the various values associated with the protein identification search such as accession number. MatchedProtOrPep points to Biosequence, enabling association of the protein identification data to the annotation available in resources such as UniProt (Apweiler et al. 2004 ). The class MatchedMetabolite, a specialized class of DataElement enables capture of the various values associated with metabolite identification search, such as name. MatchedMetabolite points to Compound (in the Biomaterial package) which enables association of metabolite identification data with the annotation available in external chemical databases. Mappings between DataElement objects (eg., ProteomicReporter, Spot, Peak MatchedProtOrPep, MatchedMetabolite) are captured via the class DataElementDataElementMapping and its association to DataElementDataElementMap a class of the BioEvent package. These classes can be used to capture any relationships existing between these DataElement members such as composition, correspondence, interaction etc. Association between DataElementDataElementMapping and DataTransformation enables the capture of the process that was used to map these elements. Selected representative classes of this package are shown in Figure 4 .
Figure 4 here Experiment
Experiment represents the container for a hierarchical grouping of bioassays. The role of this object is to enable us to understand the effect of a particular factor or set of factors on a biological system. Experiment, through its association to ExperimentDesign, provides a description and annotation of the overall experimental design as well as its rationale. ExperimentDesign is used to record annotation, such as specifying sample replicates, data quality, etc. The individual experimental factors are represented by the class ExperimentFactor, which, through its relationship to the class FactorValues provides quantitation of the factor. For instance, the dose and time of exposure to a toxic agent can be recorded using Experiment package elements. One enhancement from MAGE-OM is that in the SysBio-OM, Biosource points to FactorValue, and hence, every source biosample is linked to the experimental factor annotations. In MAGE-OM, due to lack of this association, all samples that are part of one Bioevent which records a performed BioAssay are automatically assumed to share the same experimental factors and the values.
Several other packages designed for other information pertinent to a study such as users/organizations, freetext descriptions, and the ability to specify links to predefined ontologies have been described previously (http://www.omg.org/docs/formal/03-02-03.pdf).
SummaryData
The SummaryData package was built to enable summary data to be associated with the experiment. Summary data is especially valuable for comparing data generated by cross platform technology experiments, enabling a quick view of the data without delving into too many details. The class QualitativeOrSummaryData captures this information and points to the data and the type of interpretation of that data that formed the basis for the conclusions described. Some of the representative classes of this package are shown in Figure 5 .
Figure 5 here
QuantitationType Classes in the QuantitationType package describe quantitations associated with experiment results, such as peak m/z value, peak intensity, spot coordinates, spot intensities, protein identification search results, and confidence indicators such as P value or E value.
BioSequence
The classes in the BioSequence package describe a gene or sequence. The association from BioSequence to SequenceFeature provides information regarding sequence features, such as posttranslational modification, protein motifs or other protein attributes. PostTranslationalModification, a class derived from SequenceFeature contains an attribute modificationType, which identifies a modification as being an inherent characteristic of the biosource, or a result of a bioassay treatment. Protein-protein interactions will be captured via the classes InteractionMapping and InteractionMap.
As mentioned above, an important attribute of the CEBS SysBio-OM is the ability to associate intensity data with the rich array of annotation resources currently available including UniGene (Wheeler et al. 2003) , UniProt (Apweiler et al. 2004) , and Ensembl (Birney et al. 2004) In conclusion, we believe that SysBio-OM, created by leveraging the MGED and PEDRo projects captures all data relevant for adequately annotating microarray gene expression, proteomics and metabolomics experiments. Moreover, the flexibility designed into the object model will enable representation of additional, current disciplines such as metabolomics as well as future technologies in the broad area of high-throughput genomics, proteomics, and metabolomics.
Implementation of the SysBio-OM
The implementation of the SysBio-OM is based on several open source technologies. A code generator, JavaGen, developed by Rosetta Inpharmatics and MGED available at http://sourceforge.net/projects/mged was modified and used to generate the code for the persistence classes based on the SysBio-OM. We use ObjectRelationalBridge (OJB; http://db.apache.org/ojb/) an Object/Relational mapping tool that allows transparent persistence for Java Objects against relational databases. OJB provides a flexible configuration and plugin mechanism that allows selection from a set of predefined components or implementation of custom extensions and plugins. XDoclet attributes specific to OJB are included in the code for the Java classes. XDoclet, a code generation engine, parses the meta-data attributes from the java class, and generates the OJB repository file and database schema. The OJB repository file contains a description of the mappings between the persistence classes and database objects. The Struts framework (http://jakarta.apache.org/struts/) will be used to implement the web application for the SysBio-OM. Struts has a flexible control layer based on the standard Model-View-Controller (MVC; http://java.sun.com/blueprints/guidelines/designing_enterprise_applications_2e/web-tier/web-tier5.html) design paradigm. Struts provides an extensible environment for custom extension and plugins.
Currently we are testing the database schema to ensure that all of the data generated from proteomics and metabolomics experiments can be stored appropriately. Preliminary testing with data generated from proteomics studies involving 2D gel electrophoresis and MS experiments have shown that all of the elements generated from these experiments can be stored in the SysBio-OM schema without loss of information. We are in the process of building tools for automated uploading and for querying.
A tool will be built for rendering the proteomics data in the CEBS repository into MAGE-ML and PEML formats, which are XML data representations derived from the MAGE-OM and PEDRo models, respectively. With regard to the metabolomic data, an XML format will need to be developed. The selection of format will be driven by the formats used by the repository to which the data is sent, or the repository from which data is received. Furthermore, XSLT style sheets can be used to generate other formats if required in future. This will significantly increase portability of data between different expression platforms and between different repositories, thereby providing a robust, truly cross-technology API for accessing, analyzing, and exchanging microarray gene expression, proteomics and metabolomic data.
DISCUSSION
The CEBS SysBio-OM described above provides a flexible framework to store and integrate data generated from transcriptomics, proteomics and metabolomics experiments performed on the same biological samples. We are not currently aware of any other open source model that can be used in such a manner. The usefulness of a repository storing data from multiple sources depends on its capability to enable valid comparisons among these data. In order to accomplish this, a standard must be adopted which will define the basic level of annotation that must accompany every experiment regarding the sample origin, experimental protocols, and results. Currently, a few standards are available for defining biological experiments. The microarray user community has developed the MIAME standard (Brazma et al. 2001 ) to describe the minimal information for annotation of a microarray experiment. The MIAME-Tox standard being developed jointly by the National Center for Toxicogenomics, the International Life Sciences Institute, and the European Bioinformatics Institute provides guidelines for annotating toxicogenomics experiments (http://www.mged.org/MIAME1.1-DenverDraft.DOC). We have chosen to use the PEDRo standard as a guideline to capture annotation for proteomics data. In addition, we have also included elements to represent protein-protein interaction data. The SysBio-OM supports the storage of data available from sources such as the IntAct database (http://www.ebi.ac.uk/intact/index.html), which implements the HUPO PSI MI standard (http://psidev.sourceforge.net/mi/xml/doc/user/) for the representation and annotation of protein-protein interaction data. With regard to metabolomics, this is the first open source attempt that we are aware of to capture high throughput data in a standard manner. Users will however be able to exert their own discretion in storing additional pertinent data. Such a system will enable the continual monitoring of the standard so that it can be adapted to reflect the state of art. In order to accommodate the above objectives, we have made a significant number of additions to MAGE-OM, resulting in a great increase in the size of the model. However, we believe these additions are essential to ensure comprehensive utility of the data.
The CEBS architecture supports the use of controlled vocabulary and the use of ontologies. Many groups including the MGED society are developing ontologies for several biologically relevant domains. Use of controlled vocabularies and ontologies promotes efficient storage and exchange of annotated data and enables access to multiple annotation resources. Open source controlled vocabularies and ontologies are available at http://obo.sourceforge.net/.
The CEBS architecture also facilitates the sharing of analytical tools and annotation across multiple platforms. Data from transcriptomics, proteomics and metabolomics is represented in a manner that will enable cross correlation of data from these sources. Comparison of data from these studies can be used to not only generate combinatorial groups of predictive molecular markers of disease and toxicity but also to promote an understanding of the underlying biological pathways involved under these conditions, which is a critical step in drug discovery.
In conclusion, we believe that the SysBio-OM described here presents an extensible architecture that can represent data across technologies. We hope that other members of the scientific community find this resource to be of great utility in achieving an in-depth biological meaning for their experimental data and in enabling sharing of data and technical resources.
